Abstract
Ezrin is overexpressed in a variety of neoplastic cells and involved in the later stages of tumor progression and metastasis. Ezrin expression can be regulated at both the transcriptional and post-transcriptional levels. We used a combination of bioinformatics and experimental techniques to demonstrate that the miR-204 is a direct negative regulator of ezrin. Overexpression of miR-204 mimics decreased the activity of a luciferase reporter containing the ezrin 3′ UTR and led to repression of ezrin protein. In contrast, ectopic expression of miR-204 inhibitor elevated ezrin expression. We also show that miR-204 is down-regulated in a panel of glioma tissues and in high invasive glioma cell lines we examined. Moreover, miR-204 mimics significantly reduced glioma cell migration and invasion, while miR-204 inhibitor generated the opposite results. Finally, overexpression of miR-204 and knockdown of ezrin reduced glioma cell invasion, and these effects could be rescued by re-expression of ezrin. These findings reveal that miR-204 could be partly due to its inhibitory effects on glioma cell migration and invasion through regulating ezrin expression.
Similar content being viewed by others
References
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW et al (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114:97–109
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355
Wong JW (2010) MicroRNA-induced silencing of glioma progression. J Neurosci 30:3868–3869
Lawler S, Chiocca EA (2009) Emerging functions of microRNAs in glioblastoma. J Neurooncol 92:297–306
Novakova J, Slaby O, Vyzula R, Michalek J (2009) MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386:1–5
Rao SA, Santosh V, Somasundaram K (2010) Genomewide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23:1404–1417
Srinivasan S, Patric IR, Somasundaram K (2011) A ten microRNA expression signature predicts survival in glioblastoma. PLoS ONE 6:e17438
Kim TM, Huang W, Park R, Park PJ, Johnson MD (2011) A developmental taxonomy of glioblastoma defined and maintained by microRNAs. Cancer Res 71:3387–3399
Saotome I, Curto M, McClatchey AI (2004) Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 6:855–864
Faure S, Salazar-Fontana LI, Semichon M, Tybulewicz VL, Bismuth G, Trautmann A, Germain RN et al (2004) ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation. Nat Immunol 5:272–279
Georgescu MM, Morales FC, Molina JR, Hayashi Y (2008) Roles of NHERF1/EBP50 in cancer. Curr Mol Med 8:459–468
Geiger KD, Stoldt P, Schlote W, Derouiche A (2000) Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 157:1785–1793
Tynninen O, Carpén O, Jääskeläinen J, Paavonen T, Paetau A (2004) Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 30:472–477
Mao J, Yuan XR, Xu SS, Jiang XC, Zhao XT (2013) Expression and functional significance of ezrin in human brain astrocytoma. Cell Biochem Biophys 67:1507–1511
Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154–D158
Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36:D149–D153
Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92–105
Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P et al (2005) Combinatorial microRNA target predictions. Nat Genet 37:495–500
Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10:1507–1517
Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787–798
de Ridder LI, Laerum OD, Mørk SJ, Bigner DD (1987) Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. Acta Neuropathol 72:207–213
Lam EK, Wang X, Shin VY, Zhang S, Morrison H, Sun J, Ng EK et al (2011) A microRNA contribution to aberrant Ras activation in gastric cancer. Am J Transl Res 3(2):209–218
Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X, Wang L (2012) Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting ezrin. Am J Pathol 180:2440–2451
Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586–599
Yao X, Forte JG (2003) Cell biology of acid secretion in gastric parietal cells. Annu Rev Physiol 65:103–131
Roumier A, Olivo-Marin JC, Arpin M, Michel F, Martin M, Mangeat P, Acuto O et al (2001) The membrane-microfilament linker ezrin is involved in the formation of the immunological synapse and in T cell activation. Immunity 15:715–728
Furutani Y, Matsuno H, Kawasaki M, Sasaki T, Mori K, Yoshihara Y (2007) Interaction between telencephalin and ERM family proteins mediates dendritic filopodia formation. J Neurosci 27:8866–8876
Morales FC, Molina JR, Hayashi Y, Georgescu MM (2010) Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma. Neuro Oncol 12:528–539
Chen Y, Wang D, Guo Z, Zhao J, Wu B, Deng H, Zhou T et al (2011) Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma. Cancer Res 71:1721–1729
Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T, Ben-Ze’ev A (2010) Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 123:2135–2143
Hoelzinger DB, Demuth T, Berens ME (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99:1583–1593
Demuth T, Berens ME (2004) Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70:217–228
Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83:337–376
Fillmore HL, VanMeter TE, Broaddus WC (2001) Membranetype matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neurooncol 53:187–202
Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S, Ge R et al (2009) microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res 1269:158–165
Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM (2008) MicroRNA-21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28:5369–5380
Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E (2009) MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 125:1407–1413
Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J, Ligon KL et al (2011) Human glioma growth is controlled by microRNA-10b. Cancer Res 71:3563–3572
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW et al (2012) The putative tumor suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61:278–289
Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, Sze J, Leung GK et al (2012) Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem 287:9962–9971
Ying Zhe, Li Yun, Jueheng Wu, Zhu Xun, Yang Yi, Tian Han, Li Wei et al (2013) Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res 73:990–999
Acknowledgments
This work was supported by National Natural Science Foundation of China (81300172 to K.L., 81301497 to Y.Y.Z.); Natural Science Foundation of Anhui Province (1308085QH137 to K.L., 1408085MH205 to J.M., 1408085QH148 to Y.Y.Z.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mao, J., Zhang, M., Zhong, M. et al. MicroRNA-204, a direct negative regulator of ezrin gene expression, inhibits glioma cell migration and invasion. Mol Cell Biochem 396, 117–128 (2014). https://doi.org/10.1007/s11010-014-2148-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-014-2148-6